Read + Share
Amedeo Smart
Independent Medical Education
Paik PK, Fan PD, Qeriqi B, Namakydoust A, et al. Targeting NFE2L2/KEAP1 mutations in advanced non-small cell lung cancer with the TORC1/2 inhibitor TAK-228. J Thorac Oncol 2022 Oct 11. pii: S1556-0864(22)01825.PMID: 36240971
Email
LinkedIn
Facebook
Twitter
Privacy Policy